41.54
Xoma Royalty Corp (XOMA) 最新ニュース
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
XOMA (XOMA) holders offered $39 cash plus CVRs in Ligand buyout - Stock Titan
Ligand Pharmaceuticals Launches Takeover Plan at XOMA Royalty Corporation with 47.0% Stake - TradingView
This Appian Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Thursday - Sahm
[SCHEDULE 13G] XOMA Royalty Corp Passive Investment Disclosure (>5%) - Stock Titan
H.C. Wainwright cuts XOMA stock rating on Ligand acquisition - Investing.com
HC Wainwright & Co. downgrades XOMA Royalty (XOMA) - MSN
BVF group backs XOMA Royalty Corp (XOMA) merger with 21.4% locked-up stake - Stock Titan
LGND: XOMA Buy Adds 100+ Assets - Yahoo Finance
XOMA Investors Have the Opportunity to Join Investigation of XOMA Royalty Corporation with the Schall Law Firm - GlobeNewswire
XOMA Investors Have the Opportunity to Join Investigation of XOMA Royalty Corporation with the Schall Law Firm - GlobeNewswire Inc.
Ligand to acquire XOMA Royalty - The Pharma Letter
XOMA Royalty (XOMA) Moves 10.7% Higher: Will This Strength Last? - Yahoo Finance
Ligand Pharmaceuticals to Buy XOMA Royalty for $39/Share, Lifts 2026 Guidance and EPS Outlook - MarketBeat
BlackRock (NASDAQ: XOMA) reports 5.4% stake in XOMA Royalty Corp - Stock Titan
XOMA (XOMA) closes Generation Bio acquisition, details cash-plus-CVR terms and LNP assets - Stock Titan
Are OGN, RMAX, XOMA, REAX Obtaining Fair Deals for their Shareholders? - The Malaysian Reserve
HC Wainwright & Co. maintains XOMA Royalty (XOMA) buy recommendation - MSN
Promising Biotech Stocks To Watch TodayApril 27th - MarketBeat
Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 Million - Benzinga
Ligand Is Buying Xoma Royalty For $739 Million In Cash - Finimize
Ligand Pharmaceuticals Incorporated entered into a definitive agreement to acquire XOMA Royalty Corporation for approximately $470 million from BVF Partners L.P. and others. - marketscreener.com
Ademi LLP Investigates XOMA for Possible Violations - Intellectia AI
Xoma Royalty Corp - Reuters
XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday - Benzinga
Ademi LLP Investigates Whether XOMA Royalty Corporation Is Obtaining a Fair Price for Public Shareholders - Moomoo
Ligand (Nasdaq: LGND) to acquire XOMA Royalty in $739M, EPS‑accretive deal - Stock Titan
Ligand Pharmaceuticals buying Xoma Royalty for $739 million - Yahoo Finance
Ligand Pharmaceuticals to Acquire XOMA Royalty for $739 Million, Expanding Biopharma Royalty Portfolio and Boosting 2026 EPS Guidance - Minichart
XOMA Royalty to Be Acquired by Ligand in $39-Per-Share Cash Deal Plus CVRs - TradingView
XOMA Stock Alert: Halper Sadeh LLC is Investigating Whether XOMA Royalty Corporation is Obtaining a Fair Price for its Shareholders - Business Wire
Ligand to buy XOMA Royalty (Nasdaq: XOMA) in $739M cash and CVR deal - Stock Titan
XOMA Royalty: Transaction Is Expected to Close in the 3Q of 2026 >XOMA - Moomoo
Ligand to acquire XOMA Royalty for $739 million in cash - Investing.com
Ligand to acquire XOMA Royalty for $739 million in cash By Investing.com - Investing.com Australia
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator - The Manila Times
XOMA Stock Price, Quote & Chart | XOMA ROYALTY CORPORATION (NASDAQ:XOMA) - ChartMill
XOMA Royalty (NASDAQ:XOMA) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
XOMA (XOMA) CFO converts 11,538 Performance Stock Units into common shares - Stock Titan
XOMA (XOMA) legal chief converts 3,370 PSUs into common shares - Stock Titan
XOMA (XOMA) CEO Owen Hughes exercises 10,568 PSUs and updates holdings - Stock Titan
XOMA (XOMA) CIO boosts direct common holdings via 3,737 PSU conversion - Stock Titan
XOMA Technical Analysis & Stock Price Forecast - Intellectia AI
XOMA ROYALTY CORPXOMA 8 3/8 PERP (NASDAQ:XOMAO) Checks All Eight Boxes in Navellier’s Little Book Growth Screen - ChartMill
XOMA (XOMA) CFO exercises 4,000 PSUs, 1,632 shares withheld for taxes - Stock Titan
XOMA Royalty Corporation (NASDAQ:XOMA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
XOMA Corp8.375% DP PFD B declares $0.5234 dividend - MSN
Published on: 2026-04-13 23:42:40 - baoquankhu1.vn
XOMA Royalty (NASDAQ:XOMA) Upgraded at Zacks Research - Defense World
GBIO SEC FilingsGeneration Bio Co. 10-K, 10-Q, 8-K Forms - Stock Titan
Retail Surge: Is now the right time to enter XOMA Royalty Corporation2026 Fundamental Recap & Real-Time Buy Signal Alerts - baoquankhu1.vn
XOMA Royalty (NASDAQ:XOMA) Stock Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Growth Recap: What is the next catalyst for XOMA Royalty CorporationRate Hike & Weekly Momentum Stock Picks - baoquankhu1.vn
XOMA shares climb after Q4 results top forecasts on strong royalty income - MSN
XOMA Stock Analysis: XOMA Royalty Corporation 0.30% Dip at $32.98 Deep Dive - Cổng thông tin điện tử tỉnh Lào Cai
大文字化:
|
ボリューム (24 時間):